Preserve Clinical Meaning
Maintain the intended meaning of objectives, endpoints, eligibility criteria, procedures, safety language, and operational instructions.
150+ Languages
ISO 17100 · ISO 9001 · ISO 13485
Life Sciences Linguists
Terminology & Version Control
The Protocol Sets the Foundation for Multilingual Study Content
A clinical trial protocol defines how a study is designed and conducted. It brings together objectives and endpoints, eligibility criteria, study procedures, visit schedules, investigational product information, safety requirements, assessments, reporting expectations, and operational instructions.
When a study expands across languages and countries, those concepts need to remain clear and consistent wherever they appear. Sesen treats the protocol as foundational multilingual clinical content—not an isolated translation event.
Support Consistent Study Execution
Help investigators, coordinators, pharmacists, laboratory teams, monitors, and other site personnel work from clear protocol information.
Prepare Content for Its Intended Review
Support country submissions, ethics or institutional review, investigator/site use, sponsor requirements, and multilingual study operations where applicable.
Build Downstream Consistency
Use approved protocol terminology as an important reference for ICFs, CRFs, site content, training, and other related documentation.
Clinical Protocol Content Across the Study Lifecycle
Sesen supports the core protocol content required for multinational clinical research, from initial study startup through amendments and ongoing updates.
Full Clinical Study Protocols
Complete protocols covering study design, objectives, methodology, procedures, safety requirements, assessments, statistical sections, appendices, and operational instructions.
Protocol Synopses & Summaries
Concise study overviews used by investigators, sites, reviewers, study teams, and other stakeholders.
Protocol Amendments
Substantial and non-substantial amendments, revised protocol versions, amendment summaries, tracked changes, and supporting updates.
Eligibility Criteria
Inclusion and exclusion criteria, screening requirements, participant characteristics, and clinical thresholds.
Study Objectives & Endpoints
Primary, secondary, exploratory, safety, efficacy, pharmacokinetic, pharmacodynamic, and other endpoint descriptions.
Schedules, Procedures & Assessments
Visits, time points, assessments, treatment cycles, diagnostic procedures, laboratory activities, imaging, dosing instructions, and study-specific workflows.
Safety & Operational Instructions
Safety monitoring, reporting instructions, treatment modifications, discontinuation criteria, responsibilities, and other protocol-defined requirements.
Country-Specific Protocol Content
Protocol updates, summaries, and supporting content that require controlled language handling for specific country, ethics, or institutional contexts.
From Source Protocol to Controlled Multilingual Study Content
A strong protocol workflow does more than move text from one language to another. It creates a reliable multilingual baseline that can continue to support the study when content changes.
01
Clinical Protocol
Source study design, objectives, procedures, safety, and operational content.
02
Study Terminology
Endpoints, eligibility criteria, procedures, products, abbreviations, and approved language.
03
Specialized Translation
Qualified life sciences linguists work with study context and controlled references.
04
Clinical & Linguistic Review
Independent review addresses meaning, terminology, consistency, and completeness.
05
QA & Controlled Baseline
Structured checks help establish a reviewed multilingual reference for future updates.
06
Amendments & Version Control
Changed content is identified, updated, reviewed, and aligned with the controlled baseline.
07
Connected Study Content
Protocol language informs ICFs, CRFs, site materials, training, and other related content.
08
Country & Language Rollout
Languages, regional variants, review cycles, and recurring updates are coordinated globally.
Protocol Terminology Should Stay Consistent Across the Study
Every clinical protocol develops its own language. Endpoints, eligibility criteria, investigational products, procedures, dosing, safety terminology, visits, assessments, and study-specific expressions may reappear across many downstream documents.
Endpoints
Eligibility Criteria
Investigational Product
Procedures
Dosing
Visits
Safety Language
Abbreviations
The goal is not simply to build a glossary. It is to create a reusable linguistic foundation that helps the multilingual study stay aligned over time.
Study-Specific Terminology
Identify terms carrying particular clinical, scientific, or operational meaning within the protocol.
Approved Reference Language
Incorporate sponsor glossaries, previous translations, product terminology, reference studies, and established language where available.
Terminology Reuse
Apply approved language consistently when the same concepts appear in protocol amendments and related documentation.
Linguistic QA
Check inconsistent terminology, unexplained variation, abbreviations, numbers, and other high-risk content before delivery.
Reviewer Feedback
Capture approved reviewer changes so future protocol versions and related content can reflect agreed study language.
Amendment Management
Protocol Translation Has to Stay Controlled as the Study Changes
The first approved protocol is rarely the end of the story. Eligibility criteria, visit schedules, procedures, safety information, endpoints, dosing, assessments, and operational requirements can change as the study progresses.
01
Protocol v1.0
Establish the reviewed multilingual protocol and agreed study terminology.
02
Protocol Amendment
Receive the revised source and identify additions, deletions, and modified content.
03
Change Identification
Determine which translated sections are affected and which approved content can remain unchanged.
04
Controlled Translation & Review
Translate revised material in context and apply established terminology, review, and QA.
05
Related Content Review
Identify where changed concepts may also appear in consent, CRF, site, training, manual, or safety content.
06
Updated Country Versions
Deliver updated language versions with clear protocol and amendment version identification.
Preserve Approved Language Where Appropriate
Translation memory and version comparison can help avoid unnecessary retranslation of unchanged content.
Focus Review on What Changed
Reviewers can concentrate attention on revised material while retaining the context of the approved protocol.
Maintain Terminology Across Versions
Established terminology, abbreviations, endpoint language, and study-specific expressions remain available for future amendments.
Connected Clinical Content
Keep Protocol Language Connected Across the Study
A protocol sits within a larger clinical content ecosystem. Changes made at the protocol level may need to be reflected in participant-facing, site-facing, operational, safety, and data-collection materials.
Sesen helps maintain controlled linguistic consistency, not forced identical wording. Patient communication, data collection, regulatory content, and investigator instructions serve different audiences and may require different language choices even when they originate from the same study concept.
Informed Consent Forms
Protocol procedures, visits, risks, treatment, and participant responsibilities often need to be expressed clearly in consent documentation.
Case Report Forms
Field labels, instructions, assessments, visit terminology, and data-collection content may depend directly on concepts defined in the protocol.
IRB & Ethics Materials
Protocols and amendments may be accompanied by multilingual consent materials, summaries, responses, and supporting documentation for ethics review.
Investigator Brochures
Where protocol and investigator brochure content overlap, terminology for the investigational product, safety, administration, and clinical context should remain aligned.
Study Training
Investigator meetings, site initiation, protocol training, SOPs, and eLearning may need to communicate study requirements across languages.
Clinical Site Documentation
Study manuals, pharmacy and laboratory materials, worksheets, site communications, and operational guidance frequently rely on terminology and procedures established in the protocol.
One Protocol. Multiple Languages. Multiple Country Requirements.
Multinational clinical trials create a coordination challenge as much as a translation challenge. Sesen helps sponsors and CROs manage languages, regional variants, local review cycles, staggered launches, and amendments within a controlled multilingual workflow.
Parallel Multilingual Translation
Translate multiple target languages concurrently using shared terminology, reference materials, and project instructions.
Country & Regional Variants
Manage appropriate language variants and market-specific requirements without losing alignment with the global study.
Staggered Study Launches
Support language delivery according to country startup plans rather than forcing every target into a single release schedule.
Local Reviewer Feedback
Capture, evaluate, and implement approved sponsor or in-country reviewer changes within a controlled workflow.
Amendment Propagation
Use established terminology and translated assets when revised protocols move across an existing set of countries and languages.
Version Alignment
Maintain clear source and target version identification so teams can distinguish current protocol content from superseded versions.
Because language requirements vary across countries and review contexts, Sesen plans each rollout around the study, jurisdiction, document use, and sponsor requirements.
Quality Controls Built for Complex Clinical Content
Clinical protocols combine narrative medical content with tables, numbers, units, schedules, cross-references, abbreviations, statistical language, and tightly defined study terminology. Quality assurance has to account for all of them.
Clinical Meaning
Review objectives, endpoints, eligibility criteria, procedures, interventions, safety information, and operational instructions in context.
Terminology
Apply controlled study, therapeutic-area, product, procedure, and sponsor terminology consistently throughout the protocol.
Numbers, Units & Time Points
Check doses, units, laboratory values, percentages, ranges, dates, visit windows, treatment cycles, and numerical criteria.
Tables & Schedules
Review schedules of activities, tables, footnotes, legends, headings, and repeated structured content for completeness and alignment.
Abbreviations & Cross-References
Check defined terms, acronyms, section references, tables, figures, appendices, and other internal relationships where applicable.
Completeness & Document Integrity
Account for headings, paragraphs, tables, notes, tracked changes, headers, footers, appendices, and complex multilingual formatting.
Human review remains central. Technology can identify potential issues, but clinical meaning, terminology choices, readability, and contextual judgment require qualified life sciences professionals.
Smarter Protocol Workflows Without Removing Human Control
Technology is most valuable when it helps teams improve consistency, identify change, reuse approved content, and focus expert attention where it matters.
Translation Memory
Reuse previously translated and approved protocol language when the same or similar content appears in later versions.
Terminology Management
Make established study terminology available across linguists, reviewers, amendments, and related documents.
Version Comparison
Help identify what changed between protocol versions so amendment workflows can focus on the right content.
Consistency Analysis
Identify potentially inconsistent translations of repeated terms, phrases, abbreviations, or study concepts.
Automated Quality Checks
Screen multilingual content for potential terminology, number, punctuation, omission, formatting, and consistency issues.
AI-Assisted Analysis & QA
Use AI selectively for terminology application, change analysis, consistency review, quality support, and—when appropriate to the agreed workflow—translation assistance.
Qualified life sciences professionals remain responsible for contextual judgment and final linguistic quality. AI and automation are applied as workflow advantages—not as a substitute for expert review.
Clinical & Regulatory Context
Protocol Translation in a Global Clinical Environment
Protocol translation operates within a broader framework of Good Clinical Practice, regulatory review, ethics oversight, study operations, and country-specific requirements.
Protocol language requirements vary by study and market. Sesen plans each workflow around the jurisdiction, recipient, intended use, and sponsor requirements so translated content is prepared for the context in which it will be reviewed or used.
Explore Regulatory Translation Services
ICH E6(R3) Good Clinical Practice
Current ICH GCP provides an international ethical, scientific, and quality framework for clinical trials involving human participants. Multilingual protocol content should remain fit for its intended clinical use within that quality-controlled environment.
Regulatory & Ethics Review
Translated protocol content may support health authority submissions, ethics committee or institutional review, investigator/site use, sponsor processes, and country-specific clinical operations.
Country-Specific Language Requirements
Language expectations can vary by country, authority, ethics committee, document type, and intended use. Multilingual planning should reflect the requirements that actually apply to each study and market.
Fit-for-Purpose Quality
Protocol language intended for investigators, regulators, operational teams, and ethics reviewers serves different purposes from participant-facing materials derived from the same study.
Clinical Protocol Content Is Becoming More Structured
ICH M11, the Clinical electronic Structured Harmonised Protocol (CeSHarP) framework, provides a harmonized protocol template and technical specification designed to support more consistent protocol structure and interoperable electronic exchange. As protocol information becomes more reusable, multilingual workflows increasingly need to preserve more than document-level prose.
Sesen can adapt multilingual workflows to traditional protocol documents and increasingly structured content models, with terminology, review, QA, and version control designed around the format and operational requirements of each program.
Terminology
Consistent representation of controlled clinical concepts across languages.
Content Relationships
Awareness of how protocol elements connect to one another and downstream study content.
Structured Components
Accurate handling of fields, tables, defined sections, and reusable elements.
Version History
Clear management of what changed and which language versions reflect the current protocol.
Reusable Approved Language
Carry validated terminology and translated content forward as study information is reused.
Protocol Translation for Global Clinical Research Teams
Sesen supports organizations managing clinical research across individual countries, regional programs, and complex multinational studies.
Pharmaceutical Companies
Support protocol translation from study startup through amendments, country expansion, and ongoing clinical development.
Biotechnology Companies
Scale multilingual clinical operations as programs move into new sites, markets, indications, and trial phases.
Contract Research Organizations
Coordinate protocol translation across sponsors, countries, sites, languages, timelines, and recurring study updates.
Medical Device & Diagnostic Companies
Translate clinical investigation protocols and related documentation for global device and diagnostic studies.
Academic & Research Organizations
Support multicenter and international research requiring accurate multilingual protocols and related study materials.
Emerging Clinical Development Teams
Access specialist linguistic and multilingual infrastructure without building a large internal localization operation.
Clinical Expertise Across Therapeutic Areas
Protocol linguists need to understand how terminology functions within the study design, therapeutic area, patient population, procedures, endpoints, and clinical context.
Protocol Translation in 150+ Languages
Whether a study requires one additional language or coordinated delivery across dozens of markets, Sesen can centralize terminology, project instructions, linguistic resources, reviewer feedback, translation memory, and recurring protocol updates.
150+
Native-language expertise
Regional language variants
Shared terminology framework
Coordinated global delivery
Protocol Translation FAQs
Answers to common questions about multilingual protocol workflows, amendments, terminology, quality, and global delivery.
Clinical trial protocol translation is the translation of a clinical study protocol into one or more target languages for multinational research. It can include the full protocol, protocol synopsis, amendments, eligibility criteria, objectives and endpoints, schedules of activities, procedures, safety information, tables, appendices, and other protocol content. Because the protocol defines core aspects of study design and conduct, the work requires specialized clinical terminology, careful review, structured quality controls, and consistency with related study documentation.
A protocol may need translation for country submissions, ethics committee or institutional review, investigator and site use, multinational study operations, sponsor processes, or other local requirements. There is no universal rule requiring every protocol to be translated into every local language; requirements depend on the trial, jurisdiction, intended use, authority or institution, and sponsor strategy.
Sesen can use sponsor glossaries, previous translations, product terminology, reference documentation, translation memories, terminology databases, style guidance, and approved reviewer feedback to establish study-specific language. Approved terms can then be reused across amendments and related study documentation where appropriate.
When a revised protocol is received, Sesen can compare versions to identify changed content, preserve approved translations for unchanged material, translate revised sections, apply established terminology, and perform focused review and quality assurance. This helps maintain continuity between protocol versions while supporting faster amendment cycles.
Yes. Where an existing multilingual baseline is available, translation memory, terminology resources, version comparison, established linguistic teams, and focused QA can help accelerate updates. Actual turnaround depends on language count, document length, complexity, extent of change, review requirements, formatting, and delivery scope.
Yes, where appropriate. Protocol terminology can provide an important reference for informed consent forms, case report forms, site documentation, training, investigator materials, safety content, and other study documentation. Consistent concepts do not always require identical wording, however, because patient-facing, data-collection, investigator, and regulatory content serve different audiences.
Protocol quality assurance can include checks for doses, units, ranges, percentages, dates, time points, visit windows, treatment cycles, table content, footnotes, headings, repeated text, abbreviations, and internal references. Multilingual formatting can also be provided when translated protocols require preservation or recreation of complex layouts.
Yes. Sesen supports multilingual clinical translation programs across 150+ languages. Multiple target languages can be managed in parallel using shared terminology, translation memories, project instructions, source references, quality requirements, and centralized project management.
Sesen can use AI-enabled technology within controlled clinical translation workflows when appropriate to the content, risk, and customer requirements. AI and automation may assist with translation, terminology application, consistency analysis, version comparison, repetitive content reuse, and quality checks. Qualified life sciences professionals remain responsible for contextual judgment and final linguistic quality.
Not automatically. The appropriate methodology depends on the intended use of the translated content, applicable requirements, sponsor procedures, and project specifications. Standard protocol translation typically uses professional translation, independent review, terminology control, and quality assurance rather than automatically requiring the full linguistic-validation methodology used for certain clinical outcome assessments. Additional verification steps can be incorporated when required.
Sesen assigns linguists according to the required language pair, clinical subject matter, therapeutic area, content type, and project requirements. Protocol workflows can include specialized translation, independent linguistic review, subject-matter review where required, terminology management, automated QA, and final quality control.
Where available, provide the current source protocol and version, target languages and countries, delivery dates, previous protocol translations, earlier versions, sponsor terminology or glossaries, relevant product or study references, reviewer instructions, formatting requirements, and any certification requirements. Sesen can also help determine the appropriate multilingual workflow when not all reference materials are available at project startup.
Yes. Where required, Sesen can provide translation certification or a certificate of accuracy according to the agreed project requirements. Certification requirements can vary by recipient, institution, jurisdiction, and submission context, so the required format should be confirmed during project setup.
Build a More Consistent Multilingual Study From the Protocol Forward
Sesen helps sponsors, CROs, and research teams carry the protocol's scientific, operational, and terminological foundation across languages—from initial translation and terminology control through expert review, amendments, related study documentation, and global rollout.